Roche's Acquisition of Genentech
通常価格
¥1,474 JPY
通常価格
セール価格
¥1,474 JPY
単価
あたり
税込み。
受取状況を読み込めませんでした
Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and cons of merging the two companies with different cultures, the value of Genentech, and the tactics of a hostile tender offer.
【書誌情報】
ページ数:32ページ
サイズ:A4
商品番号:HBSP-210040
発行日:2010/2/26
登録日:2011/8/9
